Emma Heming Willis, wife of Bruce Willis, shared a heartfelt message on Instagram honoring fathers living with disability or disease, reflecting on the emotional challenges of celebrating Father's Day with her husband, who is living with aphasia and frontotemporal dementia.

Brokerage firms have initiated coverage on five stocks—Federal Bank, Canara Bank, Baazar Style Retail, IKS Health, and Va Tech Wabag—from the Jhunjhunwala portfolio, which collectively have a market valuation of more than Rs 15,000 crore. These companies have seen fresh interest due to recent IPOs and financial improvements.

This article discusses the importance of National Credit Education Month in March, highlighting the potential for credit education to reduce defaults and financial stress amid concerns about a looming recession. The National Foundation for Credit Counseling (NFCC) and other financial experts emphasize the need for financial literacy, noting that most Americans are financially illiterate. The article also mentions that FICO scores are a relatively new phenomenon, and that many borrowers do not understand them. The good news is that more than two-thirds of U.S. states now require personal finance classes in high school, creating a more equitable financial education environment.

The ViVE conference in Nashville saw significant announcements from various healthcare companies focusing on technology and innovation. MultiPlan rebranded as Claritev amidst a scandal involving price-fixing. Abridge raised $250 million in a Series D funding round, expanding its clinical documentation AI capabilities. Innovaccer launched a suite of AI agents to assist healthcare professionals, while Lumeris introduced an AI tool named Tom to ease administrative work for primary care teams. UPMC Enterprises launched a virtual AI evaluation environment called Ahavi, and IKS Health unveiled a generative AI tool named Scribble Now. Symplr introduced a new operations platform to unify disparate healthcare systems.

UBS Group has reduced its price target for Fair Isaac from $2,250.00 to $2,100.00, maintaining a 'neutral' rating. Several other analysts have also adjusted their targets, with Royal Bank of Canada, Wells Fargo & Company, JPMorgan Chase & Co., Barclays, and The Goldman Sachs Group providing their own ratings and price targets. Fair Isaac's stock price has increased by 14.15% to $1,839.65, with a market cap of $44.80 billion.